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Objective. To evaluate the involvement of proinﬂammatory and oxidative stress markers in gingival tissue in individuals with
chronic periodontitis. Subject and methods. Eighteen subjects were divided in two groups: experimental (age 52.9 ± 5.0) and
control (age 51.1 ± 9.6). The activities of enzymatic antioxidants such as catalase, glutathione peroxidase (GPx), glutathione
S-transferase (GST), glutathione reductase, nonenzymatic antioxidants: total glutathione and reduced glutathione, oxidized glu-
tathione(GSSG),thiobarbituricacidreactivesubstances(TBARS),andmyeloperoxidaseactivity(MPO)wereevaluatedingingival
tissues from interproximal sites. Statistical diﬀerences between groups were determined by independent Student t test and P<. 05.
Results. Individuals with periodontal disease exhibited a signiﬁcant increase in the activities of MPO, GPx, GST, and also in TBARS
and GSSG levels in gingival tissue compared to the control group (P<. 05). Conclusion. The results of the present work showed an
important correlation between oxidative stress biomarkers and periodontal disease.
Copyright © 2007 Ivan Borges Jr. et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The inﬂammatory and immune reactions induced by the
bacterial plaque represent the main characteristics of peri-
odontitis,andthisdiseaserepresentsaparticularlycogentex-
ample of problem arising from the phenomenon [1].
Studies have demonstrated that periodontal disease af-
fects between 10% and 15% of the world’s population, rep-
resenting the greatest cause of tooth loss [2].
There is strong evidence that this disease aﬀects a spe-
ciﬁc, predisposed group of the population that presents an
exacerbated inﬂammatory/immune response to the peri-
odontopathogenic bacteria that accumulate on the teeth and
around the gingival tissue, which in turn may lead to tissue
damage [1, 3].
The exact mechanism of periodontitis development, in-
cluding the prior agents or mediators involved, is not clear.
Periodontitis manifests itself as a multifactor phenomenon,
including the generation of reactive oxygen species (ROS)
[4].
The strong evidence linking ROS to the pathological de-
struction of the connective tissue during periodontal disease
rests on the presence of neutrophils inﬁltration as the main
event in the host’s response to bacterial invasion [1, 5, 6].
Furthermore, hydroxyl radical (•OH) is most active in dam-
aging important molecules such as DNA proteins and lipids,
while hydrogen peroxide (H2O2), even not being considered
a potent ROS, is capable of crossing the nuclear membrane
and also damaging the DNA [7]. Quantitatively, the main
source of superoxide anion (O2
•−) and other ROS respon-
sible for initiation reactions is the respiratory chain. How-
ever, its presence in the periodontal tissue results ﬁrst and
foremost from the activation of phagocytes (neutrophils and
macrophages), such as antibacterial agents [1, 5, 8]. It has
been suggested that superoxide anion is involved in bone
reabsorption which has been corroborated by studies that
have demonstrated the presence of this anion in reabsorp-
tion zones adjacent to the osteoclasts [9].
The hydroxyl radical is able to initiate a classical chain
reaction known as lipid peroxidation leading to the vasodi-
lation production and rat bone reabsorption [8]. An exam-
ple of the damage caused by hydrogen peroxide is that it can
stimulate the phosphorylation of the NF-KB-IKBc o m p l e x
activating the NK-KB and facilitating nuclear translocation2 Mediators of Inﬂammation
and downstream of proinﬂammatory cytokines, including
interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-
8), β-interferon, and tumor necrosis factor-α (TNF-α) that
areveryimportantinthepathogenesisofperiodontaldisease
[10–12].
ROS production is inevitable in all aerobic organisms in-
cluding humans, who necessarily posses a complex system of
antioxidant defense [8, 13]. If the homeostasis is interrupted
in favor of ROS, an oxidative stress situation is created [13].
The aim of this study was to evaluate the involvement of
proinﬂammatory and oxidative stress markers in individuals
with chronic periodontal disease.
2. SUBJECTS AND METHODS
2.1. Experimentaldesign
This case-control study was carried out between May–
September, 2003 in a single centre (Peridontologic Centre,
Florianopolis,SantaCatarina,Brazil).Eighteensubjectswere
divided into 2 groups: experimental group (E), comprising
individuals with chronic periodontitis, age 52.9±5.0( 4m e n
and5women),withthefollowinginclusioncriteria:presence
ofchronicinﬂammation(pain,redness,heat,swelling),diag-
nosed according to bleeding on probing, at least 5 or 6 sites
withprobingdepth ≥5mm,attachmentloss ≥3mm,andex-
tensive radiographic bone loss [14]. Control group (C), was
composed of healthy individuals, age 51.1 ± 9.6( 4m e na n d
5 women) with no prior history of periodontal disease. The
probing depth in this latter group did not exceed 3mm [14].
For both groups, the following items were considered
as exclusion criteria: infection, cardiovascular and/or neu-
rological illness, renal insuﬃciency and/or diabetes; preg-
nancy; smoking; use of antibiotics and/or hormonal or non-
hormonal anti-inﬂammatory drugs 6 months prior to tissue
collection.
Inthe day of the surgicalprocedures, thepatients showed
no complication.
This study was in agreement with the ethical principles
of the World Medical Association Declaration of Helsinki
(1964).PermissionforthisstudywasobtainedfromtheEthi-
calCommittee forHumanResearchoftheFederalUniversity
of Santa Catarina (Project no. 210/2002) and the study in-
cluded only individuals that agreed to participate after read-
ing and signing a free and informed consent form, except
those with diﬃculty in understanding and communicating,
with physical handicap, or both, which could have compro-
mised the sample collection.
2.2. Assessmentofperiodontaldisease
All of the surgical procedures were assessed and performed
by a periodontist, according to the necessity for each treat-
ment. The patients with chronic periodontitis (experimen-
tal group) were submitted a pocket depth reduction tech-
nique from palatal/lingual, buccal, and interproximal sites
[15]. The biopsies were obtained from inﬂammatory gran-
ulation tissues, connective and epithelium tissues.
The samples collected from the control group were ob-
tained from quarantined mucosa during the surgical pro-
cedures of impacted third molars removed following or-
thodontic recommendation or after the reopening of dental
implants.
All samples from the experimental and control groups
were removed during the surgical and were immediately
frozeninliquidnitrogen(∼ =−170
◦C)subsequentlylatterlab-
oratory analysis.
The determinations of the inﬂammatory parameters
were made as scheduled on diﬀerent days. On the day of the
experiments, the samples were deathward at room tempera-
ture to determine the diﬀerent parameters: CAT, GPx, GST,
GR,MPOactivities,andthecontentsofT G,GSH,GSSG,and
TBARS.
2.3. Assessmentofantioxidantsenzymes
The method described by Aebi was employed to measure the
catalase activity (CAT) by measuring the decay of a freshly
prepared 10mM hydrogen peroxide solution at 240nm [16].
Glutathione peroxidase (GPx) was measured at 340nm
through the glutathione/NADPH/glutathione reductase sys-
tem by the dismutation of tert-butyl hydroperoxide [17].
Glutathione S-transferase (GST) activity was determined
at 340nm using CDNB (1-chloro-2, 4-dinitrobenzene) as
substrate and a 0.15M GSH concentration [18].
Finally, glutathione reductase (GR) activity was assayed
at 340nm by measuring the rate of NADPH oxidation
[19]. Results were expressed as mmol−1g−1(CAT) and μmol
min−1g−1 (GPx, GST, and GR).
2.4. Nonenzymaticantioxidants
Nonproteinthiols,mostlypresentasthereducedformofglu-
tathione(GSH),weremeasuredat412nmaccordingtoBeut-
ler using Elmann’s reagent (DTNB: 2-dithionitrobenzoic
acid) [20]. Immediately after thawing, acid extracts were ob-
tained by adding tissue portions to 12% trichloroacetic acid
(1:4w/v),whichwerethencentrifugedat15000gfor5min-
utes at 5◦C. Supernatants from the acid extracts were added
to a buﬀer containing 0.25mM DTNB in 0.1M Na2PO4,p H
8.0, and the formation of the thiolate anion was immedi-
ately determined. Total glutathione (TG) was also measured
at412nminacidextractsaccordingtotheenzymaticmethod
of Tietze [21]. Oxidized glutathione (GSSG) was also deter-
mined by calculating the diﬀerence (in equivalents of GSH)
between total glutathione and reduced glutathione contents.
Results were expressed as μmol g−1.
2.5. Myeloperoxidaseactivity
Myeloperoxidase activity was measured according to the
method developed by Rao et al., and was estimated by col-
orimetric measurement at 450nm on an Elisa plate reader
[22]. Results were expressed as mU/mL.Ivan Borges Jr. et al. 3
Table 1: Biomarkers of oxidative stress in gingival tissue of healthy control and individuals with periodontal disease. The results are repre-
sented by means ± SEM of controls (healthy individuals) and patients with periodontal diseases (E). CAT = Activities of Catalase, GPx =
glutathione peroxidase, GST = glutathione S-transferase, GR = glutathione reductase, MPO = myeloperoxidase, TG = total glutathione, GSH
= glutathione.
Control Experimental P
CAT (mmol min−1g−1)1 .64 ±0.46 2.00 ±0.30 .523
GPx (μmol min−1g−1)0 .80 ±0.11 2.09 ±0.34 .006∗∗∗
GST (μmol min−1g−1)4 .28 ±0.89 10.81 ±0.63 .001∗∗∗
GR (μmol min−1g−1)0 .28 ±0.04 0.22 ±0.06 .481
MPO (mU/mL) 222.20 ±54.00 556.44 ±76.77 .003∗∗∗
TG (μmol g−1)0 .44 ±0.11 0.63 ±0.09 .171
GSH (μmol g−1)0 .38 ±0.08 0.46 ±0.06 .459
SSG (μmol g−1)0 .06 ±0.01 0.17 ±0.04 .019∗∗∗
TBARS (nmol g−1) 113.07 ±16.59 188.80 ±20.73 .015∗∗∗
∗∗∗ (P<. 001) mean statistical diﬀerences between controls and experimental group.
2.6. Lipoperoxidationassay
Thiobarbituric acid-reactive substance (TBARS) contents
weredeterminedtoassessendogenouslipidoxidationingin-
gival tissue according to Ohkawa et al. [23]a n dB i r da n d
Draper [24]. After thawing, gingival portions were imme-
diately added to 12% trichloroacetic acid (1 : 4 v/v) and
were then centrifuged at 15000g for 5 minutes at 5◦C. Su-
pernatants were added to 50mM Tris-HCl pH 7.0, vortexed
for 20 seconds, added to 0.67% (w/v) 2-thiobarbituric acid,
maintained in boiling water for 60 minutes, cooled at 5◦C
for 30 minutes, and then analyzed spectrophotometrically
at 535nm. Concentrations were expressed as nmol TBARS/g
wet tissue using ∈535 = 153mM−1cm−1.
All the biochemical parameters described above were
measuredinduplicate,exceptfortheTBARSdeterminations,
which were measured in triplicate.
3. STATISTICAL ANALYSIS
The results were expressed as mean ± SEM. Statistical diﬀer-
ences between groups were determined by independent Stu-
dentt testanalysis.Forallanalyses,P<. 05wasusedtoassess
overall diﬀerences.
4. RESULTS
4.1. Antioxidantenzymeactivities
These results show that there were no signiﬁcant diﬀerences
in catalase activity in the experimental group (E) compared
to the control group (P = .523). However, a signiﬁcant
increase in GPx activities in the experimental group when
compare to the control group (P = .006) was detected (see
Table 1). Furthermore, in the experimental group, a signiﬁ-
cant increase of glutathione S-transferase (GST) values com-
pared to the control group (P = .001) was also observed (see
Table 1). The analysis of glutathione reductase (GR) revealed
no diﬀerences between the studied groups (P = .481) (see
Table 1).
4.2. Myeloperoxidaseactivity
The myeloperoxidase activity revealed a signiﬁcant increase
of this inﬂammatory biomarker in the experimental group
(P = .003) (see Table 1).
4.3. Nonenzymaticantioxidantdefenses
In relation to the total glutathione (TG) and the reduced
glutathione (GSH) contents, no diﬀerences in the values of
the experimental group compared to the control group were
found (P>. 05) (Table 1). However, the values obtained for
oxidized glutathione (GSSG) showed a signiﬁcant increase in
the experimentalgroup whencompared tothecontrolgroup
(P = .019) (see Table 1).
4.4. Measurementoftissuelipoperoxidation
Lipoperoxidation was measured through TBARS contents,
which were signiﬁcantly a higher increase in the experimen-
tal group (P = .015) (see Table 1).
5. DISCUSSION
Few studies have considered the eﬀect of the imbalance be-
tween oxidants and antioxidants in patients with periodonti-
tis, which in turn predisposes such individuals to the damag-
ing eﬀects of ROS in the periodontium [25]. Ellis and col-
laborators analyzed gingival tissues from patients with se-
vere periodontal disease and showed that the activity of cata-
lase was decreased [26]. In the present study, the activity of
catalase was not diﬀerent when the experimental and control
groups were compared. One possible explanation for these
diﬀerent responses is that the patients with periodontal dis-
ease were in distinct stages of the disease. In this regard, it
is well known that the antioxidant responses found in diﬀer-
ent pathologies depend on the severity or extension suﬀered
by the patients, and long-term chronic conditions may have
jeopardized the antioxidant defenses [8].
The analysis of the enzyme glutathione peroxidase re-
vealed a signiﬁcant increase in the experimental group.4 Mediators of Inﬂammation
A GPx increase in gingival samples from dogs and humans
with periodontal disease has already been described [6, 27].
The GPx increase may represent possible antioxidant com-
pensation in detoxiﬁcation reactions of organic peroxides
produced during oxidative stress in gingival tissue [28].
Furthermore, glutathione S-transferase (GST) also re-
vealed a signiﬁcant increase in its activities in the experimen-
tal group. Since GST has a direct role in the neutralization of
hydroperoxides derived from the lipoperoxidation processes,
increases in GST activities are probably related to the oxida-
tive stress caused by the periodontal inﬂammatory process
[8, 29]. GST comprises a group of enzymes that are also able
to detoxify a variety of compounds including xenobiotics de-
rived from pathogenic microorganisms, catalyzing their con-
jugation with GSH [30]. Hence, increases in GST activities
are excellent indicators of endogenous detoxiﬁcation from
exogenous sources [31].
The enzyme glutathione reductase (GR) has an impor-
tant accessory antioxidant function related to glutathione
peroxidase and glutathione S-transferase. GR intervention
continuously regenerates GSH from GSSG in the presence
of NADPH, therefore preventing cellular loss of GSH [32].
However, in the current study, no diﬀerences in GR activities
were detected in gingival tissue between the two groups.
The ubiquitous tripeptide glutathione (GSH) acts di-
rectly as a generic ROS scavenger or as a cofactor of GPx and
GST, either by catalyzing the reduction of hydrogen perox-
ide and lipid hydroperoxides or by the conjugation/excretion
processes of the so-called Phase II reactions [31]. Total and
reduced glutathione revealed a tendency to increase, but the
values were not signiﬁcantly diﬀerent in patients with peri-
odontitis compared to the controls.
Despite GSH, these results suggest a de novo synthesis of
glutathione, which is extremely necessary for the homeosta-
sis of cells [31]. Some periodontopathogenic bacteria deplete
GSH, and this may explain the amount of this antioxidant
was not elevated in the gingival tissue of patients with peri-
odontitis combined with an increase of the GPx activity in
the aﬀected tissue [33, 34]. A similar result was obtained in
gingival tissue and blood, but lower levels of GSH were de-
tected in the crevicular gingival ﬂuid of patients with chronic
periodontitis, when compared to normal subjects [27, 35].
On the other hand, a signiﬁcant increase in GSSG con-
centrations was detected in the experimental group, which is
a clear biomarker of oxidative stress detected in inﬂamma-
tory processes linked to periodontitis. Nevertheless, Chapple
et al. (2002) found less GSSG in gingival cervical ﬂuid of pa-
tientswithchronicperiodontitis[35].Consistentwiththere-
sults for GSSG, tissue lipoperoxidation, measured as TBARS
contents in the gingival tissue, also displayed a signiﬁcant in-
crease (P = .015) in individuals aﬀected by periodontitis,
and oxidative stress, in the gingival tissue associated with pe-
riodontal disease [36].
The systemic depletion of antioxidants clearly indicates
that in chronic periodontitis the antioxidant system is af-
fected by a relatively strong oxidation insult, which can also
deplete nutritional antioxidants such as vitamin E and C in
plasma and also vitamin E in red cell membrane [27].
Moreover, myeloperoxidase activity in gingival tissue
showed a signiﬁcant increase in patients with periodontal
disease when compared to the control group, an indicative
of a chronic inﬂammatory process also reﬂected at a sys-
temic level. These results were similar to the measurements
obtained from the analysis of crevicular gingival ﬂuid in hu-
mans with periodontal disease [37].
Oxidative stress processes and alterations in the immune
system are closely related and have been described in diﬀer-
ent diseases, thus both the aspects also seem to be linked to
the pathogenesis of periodontal disease, and can also be de-
tectedintheplasmaofpatientswithperiodontitis[8,27,35].
However, the extent to which ROS overgeneration inﬂuences
the initiation and progression of periodontal diseases is still
unknown.
In conclusion, in spite of the limited number of samples
examined in the present study, the results indicate a relation-
shipbetweenproinﬂammatoryandoxidativestressbiomark-
ers and periodontal disease.
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